NCT02068105View on ClinicalTrials.gov

A Study of ALKS 5461 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Pharmacokinetics

Interventions

DRUG

ALKS 5461

Sublingual tablet

DRUG

Placebo

Sublingual tablet

Trial Locations (1)

66212

Alkermes Investigational Site, Overland Park

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alkermes, Inc.

INDUSTRY